Mindray Medical files for Hong Kong H-share listing

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced on November 10, 2025, that it has submitted an application to The Stock Exchange of Hong Kong Limited (HKEX) for the issuance and listing of overseas-listed foreign shares (H shares) on the Main Board. The company also published its draft application materials on the HKEX website on the same day.

The subscription for this H-share offering is exclusively open to eligible overseas investors and qualified domestic institutional investors authorized to make overseas securities investments under Chinese laws and regulations. The company will not publish the application materials on domestic stock exchange websites or other approved media, but has provided links for domestic investors to access the information.

The company emphasizes that this announcement is for informational purposes only for domestic investors and does not constitute an offer or invitation to acquire, purchase, or subscribe for H shares. The listing remains subject to approval from various regulatory bodies, including the China Securities Regulatory Commission, the SFC, and HKEX.